These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anti-N and anti-Doa immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC-201: case report and review of the literature. Unnikrishnan A, Pelletier JPR, Bari S, Zumberg M, Shahmohamadi A, Spiess BD, Michael MJ, Harris N, Harrell D, Mandernach MW. Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787 [Abstract] [Full Text] [Related]
5. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease. Fasano RM, Miller MJ, Chonat S, Stowell SR. Transfus Clin Biol; 2019 May; 26(2):94-98. PubMed ID: 30837199 [Abstract] [Full Text] [Related]
6. Catastrophic Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease Without Alloantibodies: Case Report and Review of Literature. Jasinski S, Glasser CL. J Pediatr Hematol Oncol; 2019 Nov; 41(8):624-626. PubMed ID: 30179992 [Abstract] [Full Text] [Related]
7. Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions. Coleman S, Westhoff CM, Friedman DF, Chou ST. Transfusion; 2019 Jul; 59(7):2282-2291. PubMed ID: 31021439 [Abstract] [Full Text] [Related]
8. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Balbuena-Merle R, Hendrickson JE. Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806 [Abstract] [Full Text] [Related]
9. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310 [Abstract] [Full Text] [Related]
10. Relevance of blood groups in transfusion of sickle cell disease patients. Noizat-Pirenne F. C R Biol; 2013 Mar; 336(3):152-8. PubMed ID: 23643398 [Abstract] [Full Text] [Related]
12. Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease. Narbey D, Habibi A, Chadebech P, Mekontso-Dessap A, Khellaf M, Lelièvre JD, Godeau B, Michel M, Galactéros F, Djoudi R, Bartolucci P, Pirenne F. Am J Hematol; 2017 Dec; 92(12):1340-1348. PubMed ID: 28924974 [Abstract] [Full Text] [Related]
13. Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients. Ibanez C, Habibi A, Mekontso-Dessap A, Chadebech P, Chami B, Bierling P, Galactéros F, Rieux C, Nataf J, Bartolucci P, Peyrard T, Pirenne F. Transfusion; 2016 Jul; 56(7):1828-33. PubMed ID: 27145018 [Abstract] [Full Text] [Related]
14. The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis. Vamvakas EC, Pineda AA, Reisner R, Santrach PJ, Moore SB. Transfusion; 1995 Jan; 35(1):26-32. PubMed ID: 7998064 [Abstract] [Full Text] [Related]
15. Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes. Habibi A, Mekontso-Dessap A, Guillaud C, Michel M, Razazi K, Khellaf M, Chami B, Bachir D, Rieux C, Melica G, Godeau B, Galacteros F, Bartolucci P, Pirenne F. Am J Hematol; 2016 Oct; 91(10):989-94. PubMed ID: 27348613 [Abstract] [Full Text] [Related]
16. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease. Noizat-Pirenne F, Bachir D, Chadebech P, Michel M, Plonquet A, Lecron JC, Galactéros F, Bierling P. Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978 [Abstract] [Full Text] [Related]
17. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions. Pirenne F, Yazdanbakhsh K. Blood; 2018 Jun 21; 131(25):2773-2781. PubMed ID: 29724898 [Abstract] [Full Text] [Related]
18. Alloimmunization and hyperhemolysis in sickle cell disease. Pirenne F, Pondarré C. Hematology Am Soc Hematol Educ Program; 2023 Dec 08; 2023(1):653-659. PubMed ID: 38066873 [Abstract] [Full Text] [Related]
19. Anti-s antibody-associated delayed hemolytic transfusion reaction in patients with sickle cell anemia. Kalyanaraman M, Heidemann SM, Sarnaik AP, Meert KL, Sarnaik SA. J Pediatr Hematol Oncol; 1999 Dec 08; 21(1):70-3. PubMed ID: 10029818 [Abstract] [Full Text] [Related]
20. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion. Chonat S, Arthur CM, Zerra PE, Maier CL, Jajosky RP, Yee MEM, Miller MJ, Josephson CD, Roback JD, Fasano R, Stowell SR. Transfus Clin Biol; 2019 May 08; 26(2):130-134. PubMed ID: 30979566 [Abstract] [Full Text] [Related] Page: [Next] [New Search]